Target Price | €62.28 |
Price | €56.60 |
Potential |
10.04%
register free of charge
|
Number of Estimates | 16 |
16 Analysts have issued a price target Carl Zeiss Meditec 2026 .
The average Carl Zeiss Meditec target price is €62.28.
This is
10.04%
register free of charge
€90.00
59.01%
register free of charge
€41.00
27.56%
register free of charge
|
|
A rating was issued by 17 analysts: 7 Analysts recommend Carl Zeiss Meditec to buy, 8 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Carl Zeiss Meditec stock has an average upside potential 2026 of
10.04%
register free of charge
|
Sep '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion € | 2.07 | 2.19 |
1.11% | 6.02% | |
EBITDA Margin | 17.59% | 18.01% |
15.88% | 2.37% | |
Net Margin | 8.52% | 7.09% |
37.46% | 16.75% |
16 Analysts have issued a sales forecast Carl Zeiss Meditec 2025 . The average Carl Zeiss Meditec sales estimate is
This results in the following potential growth metrics:
15 Analysts have issued an Carl Zeiss Meditec EBITDA forecast 2025. The average Carl Zeiss Meditec EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
13 Carl Zeiss Meditec Analysts have issued a net profit forecast 2025. The average Carl Zeiss Meditec net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Sep '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share € | 2.01 | 1.77 |
38.15% | 11.94% | |
P/E | 31.89 | |
EV/Sales | 2.55 |
13 Analysts have issued a Carl Zeiss Meditec forecast for earnings per share. The average Carl Zeiss Meditec EPS is
This results in the following potential growth metrics and future valuations:
Carl Zeiss Meditec...
Analyst | Rating | Action | Date |
---|---|---|---|
BERENBERG |
Locked
➜
Locked
|
Locked | Mar 31 2025 |
HSBC |
Locked
➜
Locked
|
Locked | Mar 23 2025 |
METZLER EQUITIES |
Locked
➜
Locked
|
Locked | Mar 19 2025 |
HAUCK AUFHAEUSER INVESTMENT BANKING |
Locked
➜
Locked
|
Locked | Mar 11 2025 |
STIFEL EUROPE |
Locked
➜
Locked
|
Locked | Mar 04 2025 |
EQUITA SIM |
Locked
➜
Locked
|
Locked | Feb 16 2025 |
LANDESBANK BADEN-WUERTTEMBERG |
Locked
➜
Locked
|
Locked | Feb 13 2025 |
Analyst Rating | Date |
---|---|
Locked
BERENBERG:
Locked
➜
Locked
|
Mar 31 2025 |
Locked
HSBC:
Locked
➜
Locked
|
Mar 23 2025 |
Locked
METZLER EQUITIES:
Locked
➜
Locked
|
Mar 19 2025 |
Locked
HAUCK AUFHAEUSER INVESTMENT BANKING:
Locked
➜
Locked
|
Mar 11 2025 |
Locked
STIFEL EUROPE:
Locked
➜
Locked
|
Mar 04 2025 |
Locked
EQUITA SIM:
Locked
➜
Locked
|
Feb 16 2025 |
Locked
LANDESBANK BADEN-WUERTTEMBERG:
Locked
➜
Locked
|
Feb 13 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.